Literature DB >> 1987909

Amebic meningoencephalitis in a patient with AIDS caused by a newly recognized opportunistic pathogen. Leptomyxid ameba.

A P Anzil1, C Rao, M A Wrzolek, G S Visvesvara, J H Sher, P B Kozlowski.   

Abstract

A fatal case of meningoencephalitis due to a leptomyxid ameba in a patient with the acquired immunodeficiency syndrome is presented. This opportunistic organism has not been previously recognized as a human pathogen. A 36-year-old male intravenous drug abuser died after an 18-day hospital course heralded by fever and headache and followed by nuchal rigidity and hemiparesis. Computed tomography of the head showed multiple hypodense lesions. Neuropathologic examination showed that in addition to human immunodeficiency virus encephalomyelitis, there was multifocal meningoencephalitis with trophozoites and cysts morphologically indistinguishable from those of Acanthamoeba. These organisms were also found in the kidneys and adrenal glands. By immunofluorescence, the parasites showed antigenic identity with a free-living leptomyxid ameba and failed to react with any of a spectrum of antiacanthamoeba antisera. This emphasizes the importance of immunofluorescence identification of morphologically indistinguishable ameba species.

Entities:  

Mesh:

Year:  1991        PMID: 1987909

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  14 in total

1.  Demonstration of Balamuthia and Acanthamoeba mitochondrial DNA in sectioned archival brain and other tissues by the polymerase chain reaction.

Authors:  Shigeo Yagi; Frederick L Schuster; Govinda S Visvesvara
Journal:  Parasitol Res       Date:  2007-11-25       Impact factor: 2.289

2.  Demonstration of Balamuthia and Acanthamoeba mitochondrial DNA in sectioned archival brain and other tissues by the polymerase chain reaction.

Authors:  Shigeo Yagi; Frederick L Schuster; Govinda S Visvesvara
Journal:  Parasitol Res       Date:  2007-09-25       Impact factor: 2.289

3.  The Epidemiology and Clinical Features of Balamuthia mandrillaris Disease in the United States, 1974-2016.

Authors:  Jennifer R Cope; Janet Landa; Hannah Nethercut; Sarah A Collier; Carol Glaser; Melanie Moser; Raghuveer Puttagunta; Jonathan S Yoder; Ibne K Ali; Sharon L Roy
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

4.  Diagnosis of first case of Balamuthia amoebic encephalitis in Portugal by immunofluorescence and PCR.

Authors:  Marta Tavares; Jose M Correia da Costa; S Stirling Carpenter; L A Santos; Caldas Afonso; Alvaro Aguiar; Josue Pereira; Ana Isabel Cardoso; Frederick L Schuster; Shigeo Yagi; Rama Sriram; Govinda S Visvesvara
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

5.  Axenic growth and drug sensitivity studies of Balamuthia mandrillaris, an agent of amebic meningoencephalitis in humans and other animals.

Authors:  F L Schuster; G S Visvesvara
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

6.  Balamuthia mandrillaris, an opportunistic agent of granulomatous amebic encephalitis, infects the brain via the olfactory nerve pathway.

Authors:  Albrecht F Kiderlen; Ulrike Laube
Journal:  Parasitol Res       Date:  2004-07-30       Impact factor: 2.289

Review 7.  Increasing importance of Balamuthia mandrillaris.

Authors:  Abdul Matin; Ruqaiyyah Siddiqui; Samantha Jayasekera; Naveed Ahmed Khan
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 8.  Cultivation of pathogenic and opportunistic free-living amebas.

Authors:  Frederick L Schuster
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  Granulomatous amebic encephalitis: a review and report of a spontaneous case from Venezuela.

Authors:  A J Martínez; A E Guerra; J García-Tamayo; G Céspedes; J E González-Alfonzo; G S Visvesvara
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 10.  Infections in the immunocompromised child.

Authors:  Llewellyn C Padayachy; A Graham Fieggen
Journal:  Childs Nerv Syst       Date:  2018-07-11       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.